Abstract A102: First‐in‐man, first‐in‐class, pharmacokinetic and pharmacodynamic phase I clinical trial of a human monoclonal antibody CNTO888 to CC‐chemokine ligand 2 (CCL2) / monocyte chemoattractant protein (MCP‐1) in patients with advanced solid tumors

Author(s):  
Shahneen K. Sandhu ◽  
Peter C. Fong ◽  
Amita Patnaik ◽  
Kyri Papadopoulos ◽  
Christina Messiou ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document